Key result
The nicotine metabolite ratio (NMR) is a validated biomarker for personalizing smoking cessation treatment, with further research needed on its application in diverse populations and e-cigarettes.
Why the study?
To summarize evidence on the nicotine metabolite ratio as a biomarker of nicotine metabolism and evaluate its clinical utility in personalizing smoking cessation treatments.
Does using the nicotine metabolite ratio (NMR) as a biomarker improve personalized smoking cessation treatment outcomes in smokers?
Does using the nicotine metabolite ratio (NMR) as a biomarker improve personalized smoking cessation treatment outcomes in smokers?
The nicotine metabolite ratio (NMR) serves as a validated, genetically informed biomarker that can personalize and improve smoking cessation treatments.
Answers are grounded in this paper and cite their sources.
NMR may aid personalized cessation pharmacotherapy in select patients; leaves open broader validation across populations and e-cigarettes.
The nicotine metabolite ratio (NMR), a genetically informed biomarker of rate of nicotine metabolism, has been validated as a tool to select the optimal treatment for individual smokers, thereby improving treatment outcomes. This review summarizes the evidence supporting the development of the NMR as a biomarker of individual differences in nicotine metabolism, the relationship between the NMR and smoking behavior, the clinical utility of using the NMR to personalize treatments for smoking cessation, and the potential mechanisms that underlie the relationship between NMR and smoking cessation. We conclude with a call for additional research necessary to determine the ultimate benefits of using the NMR to personalize treatments for smoking cessation. These future directions include measurement and other methodologic considerations, disseminating this approach to at-risk subpopulations, expanding the NMR to evaluate its efficacy in predicting treatment responses to e-cigarettes and other noncigarette forms of nicotine, and implementation science including cost-effectiveness analyses. See all articles in this Special Collection Honoring Paul F.
No takes yet. Share an insight, caveat, or question.
Siegel et al. (2020) conducted a review in Smoking cessation. Nicotine metabolite ratio (NMR) was evaluated. The nicotine metabolite ratio (NMR) is a validated biomarker for personalizing smoking cessation treatment, with further research needed on its application in diverse populations and e-cigarettes.
Synapse has enriched 10 related papers. Consider them for comparative context: